Prevention and management of neutropenic sepsis in patients with cancer: summary of NICE guidance. BMJ 2012; 345: e5368.
Phillips, R., et al.
http://www.bmj.com/highwire/filestream/603550/field_highwire_article_pdf/0/bmj.e5368
Neutropenic sepsis is a potentially fatal complication of treatment for cancer, with mortality rates of 2-21%.
An investigation by the National Confidential Enquiry into Patient Outcome and Death and a follow-up report by the National Chemotherapy Advisory Group highlighted problems in the management of neutropenic sepsis in adults receiving chemotherapy.
No comments:
Post a Comment